OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
MIKA$1650.0058

Mitra Keluarga Karyasehat Tbk PT

Healthcare Facilities & ServicesVerified

Mitra Keluarga Karyasehat Tbk PT has a strong capital structure, with a current ratio of 4.43, indicating a solid liquidity position. The company's price-to-book ratio of 3.16 and a price-to-tangible-book ratio of 3.16 suggest that the market values the company's equity at a premium relative to its book value. The company's liquidity is further supported by a significant amount of cash and equivalents, amounting to 2,483,020,000,000 IDR. In terms of profitability, the company's return on equity of 18.81% and return on assets of 14.73% are strong indicators of its ability to generate returns for shareholders and effectively utilize its assets. These figures are in line with the industry's preferred metrics, highlighting the company's competitive position within the healthcare sector. The company's revenue is primarily concentrated in Indonesia, with no disclosed segments or geographic diversification provided in the available data. This concentration may pose a risk if the local market experiences economic downturns or regulatory changes. The company's growth trajectory is positive, with a revenue of 5,368,322,143,290 IDR and a net income of 1,364,806,709,430 IDR. Analysts have set a mean price target of 3,053.64 IDR, indicating a potential for growth in the stock price. The risk assessment for the company is low, with no immediate filing-based liquidity or dilution flags detected. The company's debt-to-equity ratio is 0.0, suggesting that it is not leveraged and has a strong equity position. Recent events and filings have not indicated any significant changes in the company's operations or financial status. The company's capital expenditure of -975,911,968,900 IDR suggests that it is investing in its operations, which could support future growth.

30-day price · MIKA-470.00 (-22.2%)
Low$1625.00High$2220.00Close$1650.00As of26 May, 00:00 UTC
Profile
CompanyMitra Keluarga Karyasehat Tbk PT
TickerMIKA.JK
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Mitra Keluarga Karyasehat Tbk PT operates as a healthcare provider in Indonesia, offering a range of medical services and facilities to generate revenue through patient care and related healthcare services.

Classification. The company is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a high confidence level of 0.92 based on verified market data.

Mitra Keluarga Karyasehat Tbk PT has a strong capital structure, with a current ratio of 4.43, indicating a solid liquidity position. The company's price-to-book ratio of 3.16 and a price-to-tangible-book ratio of 3.16 suggest that the market values the company's equity at a premium relative to its book value. The company's liquidity is further supported by a significant amount of cash and equivalents, amounting to 2,483,020,000,000 IDR. In terms of profitability, the company's return on equity of 18.81% and return on assets of 14.73% are strong indicators of its ability to generate returns for shareholders and effectively utilize its assets. These figures are in line with the industry's preferred metrics, highlighting the company's competitive position within the healthcare sector. The company's revenue is primarily concentrated in Indonesia, with no disclosed segments or geographic diversification provided in the available data. This concentration may pose a risk if the local market experiences economic downturns or regulatory changes. The company's growth trajectory is positive, with a revenue of 5,368,322,143,290 IDR and a net income of 1,364,806,709,430 IDR. Analysts have set a mean price target of 3,053.64 IDR, indicating a potential for growth in the stock price. The risk assessment for the company is low, with no immediate filing-based liquidity or dilution flags detected. The company's debt-to-equity ratio is 0.0, suggesting that it is not leveraged and has a strong equity position. Recent events and filings have not indicated any significant changes in the company's operations or financial status. The company's capital expenditure of -975,911,968,900 IDR suggests that it is investing in its operations, which could support future growth.
Key takeaways
  • Mitra Keluarga Karyasehat Tbk PT has a strong liquidity position with a current ratio of 4.43.
  • The company's return on equity of 18.81% and return on assets of 14.73% indicate strong profitability.
  • The company's revenue is primarily concentrated in Indonesia, which may pose a risk if the local market experiences economic downturns.
  • Analysts have set a mean price target of 3,053.64 IDR, indicating a potential for growth in the stock price.
  • The company's debt-to-equity ratio is 0.0, suggesting a strong equity position and no immediate liquidity or dilution flags.
  • # RATIONALES
  • margin_outlook_rationale: The company's strong profitability metrics suggest that margins are likely to remain stable or improve in the near term.
  • rd_outlook_rationale: There is no specific information provided on the company's research and development outlook.
Financial snapshot
PeriodHA-latest
CurrencyIDR
Revenue$5.37T
Gross profit$2.94T
Operating income$1.71T
Net income$1.36T
R&D
SG&A
D&A
SBC
Operating cash flow$1.93T
CapEx-$975.91B
Free cash flow$214.82B
Total assets$9.27T
Total liabilities$2.01T
Total equity$7.25T
Cash & equivalents$2.48T
Long-term debt$9.55B
Valuation
Market price$1650.00
Market cap$22.95T
Enterprise value$20.47T
P/E16.8
Reported non-GAAP P/E
EV/Revenue3.8
EV/Op income12.0
EV/OCF10.6
P/B3.2
P/Tangible book3.2
Tangible book$7.25T
Net cash$2.47T
Current ratio4.4
Debt/Equity0.0
ROA14.7%
ROE18.8%
Cash conversion1.4%
CapEx/Revenue-18.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Pharmaceuticals · cohort 779 companies
MetricMIKAActivity
Op margin31.8%7.7% medp25 -2.4% · p75 15.5%top quartile
Net margin25.4%5.9% medp25 -3.8% · p75 12.8%top quartile
Gross margin54.7%45.5% medp25 31.1% · p75 62.9%above median
R&D / revenue529.2% medp25 465.2% · p75 593.2%
CapEx / revenue-18.2%-7.0% medp25 -14.9% · p75 -3.2%bottom quartile
Debt / equity0.0%25.0% medp25 3.8% · p75 63.3%bottom quartile
Observations
IR observations
Mean price target3,053.64 IDR
Median price target3,100.00 IDR
High price target3,450.00 IDR
Low price target2,400.00 IDR
Mean recommendation1.77 (1=strong buy, 5=strong sell)
Strong-buy count5.00
Buy count6.00
Hold count2.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate103.91 IDR
Last actual EPS98.13 IDR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-22 11:30 UTC#3bf7ff91
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 14:03 UTCJob: f2900191